trifluridine has been researched along with Carcinoma, Krebs 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akulov, AE; Antonova, NM; Baiborodin, SI; Chubarov, AS; Godovikova, TS; Kaledin, VI; Kaptein, R; Koptyug, IV; Koroleva, LS; Lisitskiy, VA; Nikolin, VP; Popova, TV; Sagdeev, RZ; Silnikov, VN; Zakharova, OD | 1 |
1 other study(ies) available for trifluridine and Carcinoma, Krebs 2
| Article | Year |
|---|---|
Ligand-directed acid-sensitive amidophosphate 5-trifluoromethyl-2'-deoxyuridine conjugate as a potential theranostic agent.
Topics: Animals; Antineoplastic Agents; Carcinoma, Krebs 2; Cell Line, Tumor; Drug Carriers; Humans; Ligands; Linoleic Acid; Mice; Mice, Inbred C57BL; Polyethyleneimine; Trifluridine | 2013 |